Accès gratuit
Med Sci (Paris)
Volume 18, Numéro 4, Avril 2002
Page(s) 406 - 408
Section Le Magazine : Nouvelles
Publié en ligne 15 avril 2002
  1. Pantaloni D, Le Clainche C, Carlier MF. Mechanism of actin-based motility. Science 2001; 292 : 1502–6.
  2. Peterson JR, Lokey RS, Mitchison TJ, Kirschner MW. A chemical inhibitor of N-WASP reveals a new mechanism for targeting protein interactions. Proc Natl Acad Sci USA 2001; 98 : 10624–9.
  3. Rohatgi R, Ho HY, Kirschner MW. Mechanism of N-WASP activation by CDC42 and phosphatidylinositol 4, 5-bisphosphate. J Cell Biol 2000; 150 : 1299–310.
  4. Prehoda KE, Scott JA, Mullins RD, Lim WA. Integration of multiple signals through cooperative regulation of the N-WASP-Arp2/3 complex. Science 2000; 290 : 801–6.
  5. Suetsugu S, Miki H, Takenawa T. Identification of another actin-related protein (Arp) 2/3 complex binding site in neural Wiskott-Aldrich syndrome protein (N-WASP) that complements actin polymerization induced by the Arp2/3 complex activating (VCA) domain of N-WASP. J Biol Chem 2001; 276 : 33175–80.
  6. Abdul-Manan N, Aghazadeh B, Liu GA, et al. Structure of Cdc42 in complex with the GTPase-binding domain of the Wiskott-Aldrich syndrome protein. Nature 1999; 399 : 379–83.
  7. Kim AS, Kakalis LT, Abdul-Manan N, Liu GA, Rosen MK. Autoinhibition and activation mechanisms of the Wiskott-Aldrich syndrome protein. Nature 2000; 404 : 151–8.
  8. Egile C, Loisel T P, Laurent V, et al. Activation of the CDC42 effector N-WASP by the Shigella flexneri IcsA protein promotes actin nucleation by Arp2/3 complex and bacterial actin-based motility. J Cell Biol 1999; 146 : 1319–32.
  9. Devriendt K, Kim AS, Mathijs G, et al. Constitutively activating mutation in WASP causes X-linked severe congenital neutropenia. Nat Genet 2001; 27 : 313–7.